Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
Abbott infant formula investigation overview:
- Who: Abbott Laboratories is facing a criminal investigation.
- Why: The investigation focuses on its manufacturing of infant formula.
- Where: The investigation was revealed in a U.S. Securities and Exchange Commission filing.
Abbott Laboratories — the company behind a nationwide baby formula shortage — is now facing a criminal investigation, as well as investigations from federal financial watchdogs, it has revealed.
In a document filed with the U.S. Securities and Exchange Commission (SEC) on Feb. 17, the company disclosed it learned in November that the U.S. Attorney’s Office for the Western District of Michigan was conducting a criminal investigation into its manufacturing of infant formula.
On top of this, Abbott said it had received a civil investigative demand from the Federal Trade Commission (FTC) seeking information related to an investigation into companies that participate in bids for Women, Infants and Children (WIC) infant formula contracts.
Abbott also received a SEC subpoena requesting information on its powder infant formula business and related public disclosures in December.
The filing does not provide further detail on the investigations or how they might affect investors.
Abbott infant formula contamination led to multiple investigations, lawsuits
Abbott’s Similac, Alimentum and Elecare baby formula products were recalled due to possible contamination in February 2022.
The FDA then required Abbott to shut down its Sturgis, Michigan, facility after Similac baby formula produced at the plant was linked to cronobacter sakazakii and salmonella newport contamination that sickened several infants and led to two deaths.
This led to a nationwide baby formula shortage, which forced the United States to import millions of pounds of baby formula.
An FDA investigation into the factory didn’t find a genetic link between bacteria found at the plant and the bacteria that sickened the babies, but the agency said its inspections of the plant turned up “shocking” lapses in safety protocol and unsanitary conditions at the plant.
Abbott is facing various lawsuits over its baby formula, including multidistrict litigation alleging it caused a deadly illness in premature babies.
If your child developed a bacterial infection after consuming recalled Abbott baby formula products, you may qualify to participate in an Abbott baby formula injuries lawsuit investigation.
Don’t Miss Out!
Check out our list of Class Action Lawsuits and Class Action Settlements you may qualify to join!
Read About More Class Action Lawsuits & Class Action Settlements:
- Abbott Laboratories Similac formula false advertising $19.5M class action settlement
- ProSobee Simply Plant Based Infant Formula recalled due to possible bacterial contamination
- Robitussin class action claims Naturals cough syrup falsely advertised, contains artificial ingredients
- Tampax class action claims Pure Cotton tampons falsely advertised
Honda, Hyundai, Kia, Subaru vehicle data collection class action lawsuit investigation
May 17, 2024 | Legal News
